Pre-market Hot Trades in US Stocks

MV Oil Trust is up 8.64% in pre-market trading. Based on recent news,

1. On July 14, MV Oil Trust approached liquidation and delisting, with traditional yield assets gradually disappearing. Investors' concerns about geopolitical and inflation risks increased, leading them to turn to safe-haven assets, driving up the stock price.

2. On July 14, SPROTT PHYSICAL GOLD TRUST attracted more investor attention as a safe-haven asset, indirectly affecting the market performance of MV Oil Trust.

3. On July 14, the micro differentiation in the biotechnology and human resources sectors further highlighted the current economic expansion's imbalance, with the market eagerly anticipating the upcoming Q2 2026 earnings season, increasing market volatility. The demand for safe-haven assets rose, pushing related stocks higher.

Teradyne is down 3.02% in pre-market trading. Based on recent key news:

1. On July 16, JP Morgan raised Teradyne's target stock price from $400 to $450, showing market confidence in its future performance. However, analysts' ratings did not immediately reflect in the stock price.

2. On July 15, Teradyne announced it would release its Q2 earnings report on July 28 and hold a conference call on July 29. Investors are taking a wait-and-see approach to the upcoming earnings report, leading to stock price fluctuations.

3. On July 15, market analysis showed that although Teradyne has outperformed the market over the past five years, it is currently not listed as one of the top analyst-recommended stocks, which may affect investor confidence. The semiconductor industry has been volatile recently and requires attention.

Top Gainers in Pre-market US Stocks

AtaiBeckley is up 62.86% in pre-market trading. Based on recent news,

1. On July 16, Bloomberg reported that Eli Lilly is close to reaching an agreement to acquire psychedelic drug manufacturer AtaiBeckley, with the deal possibly announced this week. This news propelled AtaiBeckley’s stock price to soar 66% in pre-market trading.

2. On July 16, AtaiBeckley focuses on developing treatment solutions based on psychedelic drugs, with its core candidate BPL-003 being a nasal spray for treating treatment-resistant depression, which has received FDA "Breakthrough Therapy" designation. This news further boosted market confidence.

3. On July 16, all 15 brokerages covering AtaiBeckley stock gave it a "Buy" or higher rating, with a median target price of $14. This rating supports investor optimism. There is increased market interest in the psychedelic drug sector, with an improving regulatory environment.

Agape ATP is up 38.89% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation The Growhub pre-market rose 36.38%. Based on recent key news:

1. On July 15, The Growhub Ltd. released an important announcement through the EDGAR system of the U.S. Securities and Exchange Commission. This announcement may contain key information regarding the company's future development, leading to a significant increase in market demand for its stock, pushing the stock price up 36.38% in pre-market trading. Source: EDGAR system, increased market demand for tech stocks, significant capital inflow